Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

Contraception
S KoetsawangE S Kononova

Abstract

This paper investigates the relationship between pregnancy rates and body weight of 1005 women using a vaginal ring releasing 20 micrograms levonorgestrel per 24 hours. While the overall pregnancy rate at one year was 3.7%, it was found that women have an increasing risk of pregnancy with increasing body weight. For example, a woman of 40 kg has an estimated pregnancy rate of 1.7% in contrast to 9.8% for a woman of 80 kg weight.

References

May 1, 1979·Contraception·F G BurtonG W Duncan
Feb 16, 1974·British Medical Journal·J Bonnar

❮ Previous
Next ❯

Citations

Dec 1, 1996·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M Bygdeman
Mar 1, 1992·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·X F LiJ Newton
Dec 12, 2012·International Urogynecology Journal·Sushma Srikrishna, Linda Cardozo
Nov 6, 2013·Antiviral Research·David R FriendMeredith R Clark
Oct 9, 2012·Contraception·Vivian BracheAníbal Faundes
May 27, 1993·The New England Journal of Medicine·D T Baird, A F Glasier
Feb 24, 2001·Clinical Obstetrics and Gynecology·S A Ballagh
Nov 17, 2007·Current Opinion in Obstetrics & Gynecology·Risto Erkkola
May 1, 1994·Journal of the American Academy of Nurse Practitioners·J WalthallM H Hutti
Aug 13, 2011·Infectious Diseases in Obstetrics and Gynecology·Andrea Ries ThurmanGustavo F Doncel
Apr 1, 1993·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A E Schindler
Jan 7, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·David R Friend
Jun 21, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shweta R UgaonkarThomas M Zydowsky
Apr 11, 2015·Advanced Drug Delivery Reviews·Sophia G Antimisiaris, Spyridon Mourtas
Jul 9, 2004·Fertility and Sterility·Nancy J AlexanderEdio Zampaglione
Apr 1, 1993·Annals of Medicine·D R Mishell
Nov 22, 2005·Expert Opinion on Drug Delivery·Regine Sitruk-Ware
Sep 23, 2008·Expert Review of Medical Devices·Giuseppe BenagianoManuela Farris
Mar 13, 2012·Best Practice & Research. Clinical Obstetrics & Gynaecology·Zeda F Rosenberg, Brid Devlin
Jul 31, 2016·International Journal of Pharmaceutics·Peter BoydR Karl Malcolm
Aug 19, 2016·The Cochrane Database of Systematic Reviews·Laureen M LopezFrans M Helmerhorst
Oct 6, 2018·Expert Opinion on Pharmacotherapy·Ilza MonteiroLuis Bahamondes
Feb 1, 1991·Statistics in Medicine·E M Belsey, N Carlson
Jun 1, 1992·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·I C ChiS Balogh
Jul 21, 2020·Expert Opinion on Drug Delivery·Peter BoydR Karl Malcolm
Jun 1, 1991·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·E M Belsey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.